Cell News and Research

RSS

Strategy to treat obesity through molecular liposuction

Researchers at The University of Texas M. D. Anderson Cancer Center have designed a strategy to treat obesity through “molecular liposuction.” The therapy destroys blood vessels supporting fat accumulation — causing the fat to rapidly break down and disappear.

10 May 2004

Vegetables yield anticancer chemical

Plant chemicals created during the preparation of some vegetables could kill colon cancer cells in a similar way to some cancer drugs.

10 May 2004

New studies on the diagnosis of interstitial cystitis and the treatment of prostatitis

Antimicrobials Ineffective in Treating Chronic Prostatitis / Pelvic Pain Syndrome (CP/PPS): Though the traditional means of treating men with CP/PPS, use of antibiotics and alpha-adrenergic receptor blockers (tamsulosin and ciprofloxacin) did not lead to significant change after six and 12 weeks of treatment.

10 May 2004

Bone marrow and stem cell transplantation rejection averted by UV light exposure

One of the unfortunate side effects of bone marrow and stem cell transplantation is that the newly implanted cells often stage an internal attack against the patient they're intended to help.

10 May 2004

Soybeans may reduce the risk of colon cancer

A substance found in soybeans may reduce the risk of colon cancer, the third most common form of cancer in the world according to the World Health Organization.

10 May 2004

New chink in the cellular armor of tuberculosis (TB) and leprosy

The family of bacteria that causes tuberculosis (TB) and leprosy are notoriously sturdy. And although the diseases they cause have been held in check for the past 50 years by antibiotics, some strains are becoming increasingly resistant to existing therapy.

10 May 2004

No evidence of CJD associated with the Garden State Racetrack

The Department of Health and Senior Services released a report today on an investigation of a suspected cluster of Creutzfeldt-Jakob Disease (CJD) associated with the Garden State Racetrack.

8 May 2004

Discovery of immune system malfunction that plays a profound role in food allergy

A team of scientists, led by the Institute of Food Research (IFR) in the UK, has discovered an immune system malfunction that is likely to play a profound role in food allergy.

8 May 2004

New way by which cells can become cancerous may solve mystery with lung cancer

Researchers at The University of Texas M. D. Anderson Cancer Center are describing an entirely new way by which cells can become cancerous. And they say their finding provides an answer to a mystery in lung and other cancers.

8 May 2004

Britain debates whether to create DNA registry of newborn babies

In a White Paper published last year the Government asked the Human Genetics Commission and the National Screening Committee to consider the case for screening every baby at birth and storing their genetic profile for future use.

7 May 2004

Researchers find an entirely new way by which cells can become cancerous

Finding provides an answer to a mystery in lung and other cancers: why a potent tumor suppressor gene called FUS1 functions as it should, yet none of the protein it produces can be found anywhere in a cancer cell.

6 May 2004

New stent appears safe and effective for preventing arteries from reclosing in coronary heart disease patients

A new stent appears safe and effective for preventing arteries from reclosing in coronary heart disease patients, based on one-year results of the first human trial using this stent reported in today’s rapid access issue of Circulation: Journal of the American Heart Association.

6 May 2004

The First International Congress on Antioxidant Methods

The First International Congress on Antioxidant Methods will be held June 16-18 in Orlando, Fla., in an effort to reach agreement on techniques for measuring and reporting on antioxidants, beneficial compounds found in foods, cosmetics and certain vitamins that are believed to fight cancer, heart disease and aging.

6 May 2004

A second-generation targetted antibody for potential cancer therapy

The overproduction, or 'overexpression', of the epidermal growth factor receptor (EGFR) is one of the most common aberrations in cancer, and subsequently agents that inhibit EGFR are among the most hotly-pursued potential products in the pharmaceutical industry.

6 May 2004

System Biosciences launches siRNA expression libraries to target 8,500 human genes

The siRNA libraries contain 7,500 and 43,800 siRNA template sequences that target 1,500 and 8,500 well-characterized human genes, respectively.

6 May 2004

Protein in the male reproductive tract is a potent anti-bacterial agent

Scientists at the University of North Carolina at Chapel Hill have found that a protein they discovered three years ago in the male reproductive tract is a potent anti-bacterial agent.

6 May 2004

World's first gene therapy trial aimed at preventing cancer

The concept seems straightforward. If, at its heart, cancer is a disease of genes, then giving patients new genes should disarm cancer. Such treatment would replace missing or faulty genes that keep cell growth in check, or would flush the body with "super genes" that could attack and destroy cancer.

5 May 2004

Trial of antibody for HIV Infection

Tanox, Inc. announced today that it has begun dosing patients in its Phase 2 clinical trial of TNX-355 for the treatment of the human immunodeficiency virus (HIV).

5 May 2004

New studies put spotlight on replicative capacity of beta cells

Researchers at Harvard University and the Howard Hughes Medical Institute (HHMI) have discovered that insulin-producing beta cells in the pancreas that are attacked in type 1 diabetes are replenished through duplication of existing cells rather than through differentiation of adult stem cells.

5 May 2004

New insight into the function of RNA helicases

If DNA can be compared to an architect who gets all the glory for designing the building, RNA can be compared to the engineer who often goes unrecognized, but is needed to turn the blueprints into a real three-dimensional, functional and safe structure.

5 May 2004

Cell News and Research

Strategy to treat obesity through molecular liposuction

Vegetables yield anticancer chemical

New studies on the diagnosis of interstitial cystitis and the treatment of prostatitis

Bone marrow and stem cell transplantation rejection averted by UV light exposure

Soybeans may reduce the risk of colon cancer

New chink in the cellular armor of tuberculosis (TB) and leprosy

No evidence of CJD associated with the Garden State Racetrack

Discovery of immune system malfunction that plays a profound role in food allergy

New way by which cells can become cancerous may solve mystery with lung cancer

Britain debates whether to create DNA registry of newborn babies

Researchers find an entirely new way by which cells can become cancerous

New stent appears safe and effective for preventing arteries from reclosing in coronary heart disease patients

The First International Congress on Antioxidant Methods

A second-generation targetted antibody for potential cancer therapy

System Biosciences launches siRNA expression libraries to target 8,500 human genes

Protein in the male reproductive tract is a potent anti-bacterial agent

World's first gene therapy trial aimed at preventing cancer

Trial of antibody for HIV Infection

New studies put spotlight on replicative capacity of beta cells

New insight into the function of RNA helicases

What are the challenges of cell line development? eBook

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest Life Science News